Quick test finds signs of sepsis in a single drop of blood
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
A team of researchers from the University of Illinois and Carle Foundation Hospital in Urbana, Illinois, completed a clinical study of the device, which is the first to provide rapid, point-of-care measurement of the immune system’s response, without any need to process the blood.
This can help doctors identify sepsis at its onset, monitor infected patients and could even point to a prognosis, said research team leader Rashid Bashir, a professor of bioengineering at the U. of I. and the interim vice dean of the Carle Illinois College of Medicine. The researchers published their findings in the journal Nature Communications.
Sepsis is triggered by an infection in the body. The body’s immune system releases chemicals that fight the infection, but also cause widespread inflammation that can rapidly lead to organ failure and death.
Sepsis strikes roughly 20 percent of patients admitted to hospital intensive care units, yet it is difficult to predict the inflammatory response in time to prevent organ failure, said Dr. Karen White, an intensive care physician at Carle Foundation Hospital. White led the clinical side of the study.
“Sepsis is one of the most serious, life-threatening problems in the ICU. It can become deadly quickly, so a bedside test that can monitor patient’s inflammatory status in real time would help us treat it sooner with better accuracy,” White said.
Sepsis is routinely detected by monitoring patients’ vital signs – blood pressure, oxygen levels, temperature and others. If a patient shows signs of being septic, the doctors try to identify the source of the infection with blood cultures and other tests that can take days – time the patient may not have.
The new device takes a different approach.
“We are looking at the immune response, rather than focusing on identifying the source of the infection,” Bashir said. “One person’s immune system might respond differently from somebody else’s to the same infection. In some cases, the immune system will respond before the infection is detectable. This test can complement bacterial detection and identification. We think we need both approaches: detect the pathogen, but also monitor the immune response.”
The small, lab-on-a-chip device counts white blood cells in total as well as specific white blood cells called neutrophils, and measures a protein marker called CD64 on the surface of neutrophils. The levels of CD64 surge as the patient’s immune response increases.
The researchers tested the device with blood samples from Carle patients in the ICU and emergency room. When a physician suspected infection and ordered a blood test, a small drop of the blood drawn was given to the researchers, stripped of identifying information to preserve patient confidentiality. The team was able to monitor CD64 levels over time, correlating them with the patient’s vital signs. Researchers found that the results from the rapid test correlated well with the results from the traditional tests and with the patients’ vital signs.
“By measuring the CD64 and the white cell counts, we were able to correlate the diagnosis and progress of the patient – whether they were improving or not,” said Umer Hassan, a postdoctoral researcher at Illinois and the first author of the study. “We hope that this technology will be able to not only diagnose the patient but also provide a prognosis. We have more work to do on that.”
Bashir’s team is working to incorporate measurements for other inflammation markers into the rapid-testing device to give a more complete picture of the body’s response, and to enable earlier detection. They also have a startup company, Prenosis Inc., that is working to commercialize the device.
“We want to move the diagnosis point backward in time,” Bashir said. “The big challenge in sepsis is that no one knows when you get infected. Usually you go to the hospital when you already feel sick. So the goal is that someday you can be testing this at home, to detect infection even earlier if you can.”
The Latest on: Sepsis
- Sepsis causes more deaths worldwide than previously thoughton January 17, 2020 at 1:18 pm
Sepsis kills more than twice as many people worldwide as once believed, and children in poor regions account for an excessive number of such deaths, researchers say. Sepsis is an out-of-control immune ...
- Study quashes the idea of using vitamin C-based cocktail for treatment of sepsison January 17, 2020 at 8:02 am
In 2017 a paper was published asserting that intravenous vitamin C given to patients with sepsis was literally a life saver. Despite the study only looking at 47 subjects the results garnered ...
- Sepsis Causes Far More Deaths Worldwide Than Thoughton January 17, 2020 at 7:31 am
FRIDAY, Jan. 17, 2020 (HealthDay News) -- Sepsis kills more than twice as many people worldwide as once believed, and children in poor regions account for an excessive number of such deaths, ...
- Study sets the record straight on unproven therapy to treat sepsison January 17, 2020 at 6:39 am
The Jan. 17 issue of the Journal of the American Medical Association (JAMA) features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert.
- Vitamin Treatment For Sepsis Fails In Large Trialon January 17, 2020 at 4:09 am
Hope for an effective and inexpensive treatment for the deadly condition sepsis has dimmed following results of a major new study. Researchers had hoped that a simple treatment involving infusions of ...
- Sepsis 'behind one in five deaths worldwide' - what is the condition?on January 17, 2020 at 2:50 am
Sepsis may be behind one in five deaths globally, research suggests. Scientists from the universities of Pittsburgh and Washington found 48.9m people developed the life-threatening condition in 2017, ...
- Latest News 2020 Sepsis Therapeutics Market Dominating as Companies Collaborate on Technology to Improve Sepsis Careon January 17, 2020 at 12:51 am
The Sepsis Therapeutics Market 2020 research report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross ...
- Sepsis Linked To 1-in-5 Deaths Worldwide: Studyon January 16, 2020 at 5:10 pm
Sepsis played a direct role in the deaths of 11 million people in 2017, almost twice as many as previously estimated, according to a study published Thursday. That represents one death for every five ...
- Sepsis, the 'hidden killer,' may be responsible for 1 in 5 deaths worldwide, study showson January 16, 2020 at 2:47 pm
Sepsis is likely responsible for one in five deaths worldwide — more than cancer — each year, according to a new study.
- 'Alarming' one in five deaths due to sepsison January 16, 2020 at 11:15 am
One in five deaths around the world is caused by sepsis, also known as blood poisoning, shows the most comprehensive analysis of the condition. The report estimates 11 million people a year are dying ...
via Google News and Bing News